Do Peritoneal Nebulization of Ropivacaine Reduce the Use of Morphine After Short Gynecologic Laparoscopic Surgery?

NCT01142622 Phase 3 COMPLETED

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg may prevent the use of morphine during the first day after laparoscopic ovarian cyst surgery.

Details

Lead sponsor	San Gerardo Hospital
Phase	Phase 3
Status	COMPLETED
Enrolment	140
Start date	2010-04
Completion	2012-12

Conditions

• Ovarian Cysts

Interventions

• Ropivacaine nebulization
• Ropivacaine instillation

Primary outcomes

• Morphine consumption (mg) — Up to 24 hours
  The total dose of morphine at every evaluation after awakening will be quantified using the PACU clinical chart and/or PCA infusers memory display.

Countries

Italy